AGP Picks
View all

Chronic fatigue syndrome treatment market seen growing to $3.07 billion by 2030

Nov. 18, 2026
Chronic fatigue syndrome treatment market seen growing to $3.07 billion by 2030
By AI, Created 17:00 UTC, Nov 18, 2026, AGP -

The chronic fatigue syndrome treatment market is projected to rise from $2.09 billion in 2025 to $2.26 billion in 2026, driven by greater clinical recognition and wider use of non-drug care. The Business Research Company says the market could reach $3.07 billion by 2030 as personalized, multidisciplinary treatment models gain ground.

Why it matters: - The chronic fatigue syndrome treatment market is expanding as clinicians, hospitals and patients look for more structured ways to manage a complex condition with persistent fatigue. - The shift toward non-pharmacological care could reshape treatment pathways and support demand for psychological therapies, symptom management programs and digital health tools. - The market outlook signals continued investment in care models aimed at improving quality of life rather than only treating isolated symptoms.

What happened: - The Business Research Company released its Chronic Fatigue Syndrome Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Nov. 18, 2026. - The report says the market will grow from $2.09 billion in 2025 to $2.26 billion in 2026. - The report projects the market will reach $3.07 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - The 2026 growth rate is projected at 8.2% CAGR. - The forecast through 2030 implies a 7.9% CAGR. - Market growth is tied to greater clinical recognition of chronic fatigue syndrome. - Hospital-based fatigue management programs are contributing to demand. - Use of antidepressants and sleep aids is supporting treatment-market activity. - Broader acceptance of cognitive behavioral therapy is also helping drive growth. - Patient advocacy and awareness are adding momentum to the market. - The report says intensified research into the biological causes of chronic fatigue syndrome will support future growth. - Rising demand for holistic and personalized care approaches is expected to expand the market further. - Digital health support tools are becoming part of treatment strategies. - The market is benefiting from a stronger focus on long-term quality of life. - Multidisciplinary treatment strategies are gaining adoption. - The report highlights growing use of integrated treatment protocols. - Non-pharmacological therapies are taking a larger role in care. - Enhanced symptom management programs are emerging as a market trend. - Personalized treatment plans and patient-centered care models are also shaping the market. - Chronic fatigue syndrome treatment focuses on managing symptoms, boosting energy levels and improving overall quality of life. - The treatment approach is designed to support functional recovery and long-term wellness. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The report also adds key technologies and future trend analysis. - A free sample is available through the company's sample request page. - The full report is available through the company's report page.

Between the lines: - The market’s growth is being driven less by a single drug breakthrough and more by a broader shift toward supportive, multidisciplinary care. - The report frames chronic fatigue syndrome as a condition where safer, patient-focused management is replacing more aggressive intervention strategies. - The emphasis on non-drug approaches suggests healthcare providers are looking for treatments that are more adaptable to long-term symptom control.

What's next: - The market is expected to keep expanding as research, digital support and personalized treatment models mature. - Adoption of non-pharmacological care is likely to remain a major demand driver in hospitals and specialty settings. - Regional momentum in Asia-Pacific may narrow the gap with North America over the forecast period. - The Business Research Company’s expanded report tools are aimed at helping buyers track trends, forecasts and competitive positioning.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

LATAM News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

LATAM News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.